Vanguard Group Inc Lumos Pharma, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 244,082 shares of LUMO stock, worth $566,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244,082
Previous 244,082
-0.0%
Holding current value
$566,270
Previous $776,000
11.34%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LUMO
# of Institutions
42Shares Held
2.29MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA416KShares$964,0780.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$943,3390.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny218KShares$505,7920.0% of portfolio
-
Acuitas Investments, LLC141KShares$326,3980.21% of portfolio
-
Jefferies Financial Group Inc. New York, NY121KShares$279,9100.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $19.5M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...